VITAL SIGNALS LAUNCHES $399 BLOOD PRESSURE RING

The Signal Ring provides both systolic and diastolic blood pressure readings without requiring a traditional cuff. The device uses algorithmic monitoring to track readings continuously, potentially reshaping how patients manage hypertension and cardiac conditions. The company positions the wearable as a breakthrough in consumer health tech. At $399, the Signal Ring targets users seeking convenient, ongoing blood pressure monitoring. Vital Signals claims its technology matches the accuracy of conventional arm cuff measurements. The startup has indicated future versions could move beyond monitoring into diagnostic capabilities. The announcement represents a significant step toward mainstream adoption of ring-based health monitoring. Success would depend on FDA validation and widespread user adoption.